New Copper Nanozyme Shows Powerful Tumor Suppression With High Precision

Researchers have developed a copper-based single-atom nanozyme capable of suppressing malignant tumors with high precision while minimizing side effects. This breakthrough addresses the major challenge of limited precision in current malignant tumor treatments that often cause significant collateral damage. The technology represents a potential paradigm shift in oncology, moving from broad-spectrum chemotherapy to targeted molecular intervention.